A Tradition of Leadership
Hematologic malignancies are cancers of the blood that manifest themselves in several ways. The Hematology Program of Mayo Clinic Cancer Center has a strong tradition of advanced research focused on improving the diagnosis and treatment of hematologic diseases. Mayo Clinic’s myeloma program is the oldest and largest in the country, and Mayo hematology researchers have been recognized by a number of funding agencies as well as their peers for many discoveries.
The incidence of blood cancers has increased 40 percent in the past two decades, and Mayo investigators will continue leading the research into the causes behind these diseases, and the development of better, targeted treatments.
Members of the program range from nationally- and internationally-recognized investigators to young researchers who demonstrate significant productivity and promise. The Program has multiple areas of expertise including, hematology, genomics and basic sciences, pathology and cytogenetics, immunology and biochemistry.